ENHANCED RESISTANCE TO STREPTOCOCCAL INFECTION INDUCED IN MICE BY CELL WALL MUCOPEPTIDE by Rotta, Jiri et al.
ENHANCED  RESISTANCE  TO  STREPTOCOCCAL  INFECTION 
INDUCED  IN  MICE  BY  CELL  WALL  MUCOPEPTIDE* 
BY JIRI ROTTA,~ PH.D., THOMAS J. PRENDERGAST,§  WALTER  W. 
KARAKAWA,  H PH.D., CHARLES K. HARMON,§ AND RICHARD 
M.  KRAUSE, M.D. 
(From the Department of Preventive Medicine, Washington University School of Medicine 
St. Louis) 
(Received for publication, June 16, 1965) 
Stetson has reported that disrupted hemolytic streptococci contain an active 
material with properties similar to those of endotoxin (1). In these experiments 
the  cell walls were removed from the  disrupted  bacterial suspension by cen- 
trifugation, and the endotoxin properties were associated with the superuatant. 
Raska and  Rotta have reported  that mice injected with  Group A  cell walls 
exhibited  enhanced  resistance  to  subsequent  challenge  with  a  homologous 
type of Group A streptococci (2). One of the characteristic properties of endo- 
toxin is the capacity to induce enhanced non-specific resistance following in- 
jection into mice (3). In view of the fact that these two experiments employed 
different fractions  of  disrupted  streptococci,  these  biological  properties may 
be dependent upon more than one streptococcal substance. On the other hand, 
a  single cellular material may have been distributed in both the cytoplasmic 
and  cell  wall fractions.  The  present  studies  were  undertaken  to  clarify  the 
status of streptococcal material which possesses endotoxin properties. Particu- 
lar attention has been directed to the identification of a  cell wall constituent 
which  enhances  the  resistance of mice to subsequent  challenge  with  strepto- 
cocci. 
Materials and Methods 
Streptococcal Strains.--Group  A streptococci Type 6  (Strain $43/100/13)  and Type 14 
(Strain PY) were employed for mouse inoculations. Strain $43/100/13, Type 6, was obtained 
* This investigation was supported in part by National Institutes  of Health grants No. 
06154, National Institute of Allergy and Infectious Diseases, and No. 08027, National Heart 
Institute; in part by the Missouri-St. Louis Heart Association; and was conducted in part 
under  the  sponsorship of  the  Commission on  Streptococcal and  Staphylococcal Disease, 
Armed Forces Epidemiological  Board, and was supported by the Office  of the Surgeon Gen- 
eral, Department of the Army, Washington, D. C. 
:~ Present address: Institute of Epidemiology and  Microbiology, Srobarova 48,  Prague, 
Czechoslovakia. 
§ Predoctoral trainee in epidemiology,  National Institutes of Health training grant  5 T1 
GM807, Research Training Branch. 
]1 National  Institutes  of Health  trainee in epidemiology, training grant  5 T1  GM 807, 
Research Training Branch. 
877 878  STREPTOCOCCAL INFECTIONS 
from Dr. R. C. Lancefield, the Rockefeller University, New York, and strain PY from Dr. 
T. Mortimer, Western Reserve University, Cleveland. 
Mice.--Male mice, Webster strain, weighing 18 to 22 gm were employed. The mice were 
fed a diet of Purina chow and water. 
Preparation of Streptococcal Challenge Dose.--One  ml aliquots  of a  stock  culture  of the 
streptococcal strains were stored at -70°C. On the day of challenge the aliquot was thawed, 
added  to 50 ml of Dffco brain heart  infusion, and  incubated  at  37°C for 6 hours.  Colony 
counts on these cultures were 2 to 5  X  l0  s per ml. An appropriate  dilution of the culture 
was employed as the inoculum for mice. 
The Cultivation of Mouse Specimens for Streptococci and L  Forms.--The following speci- 
mens from infected mice were cultured on sheep blood agar: mouse blood collected prior to 
death by means of a retroorbital puncture with a  sterile heparin capillary tube; at autopsy, 
hearts' blood, kidney, spleen,  liver, and peritoneal fluid. 
In addition to regular bacteriologic examination,  the autopsy materials were cultured on 
an L form agar medium consisting of 3.7 per cent Difeo brain heart infusion, 2 per cent NaCI, 
1.1 per cent agar,  10 per cent horse serum, and 0.5 per cent yeast extract. The horse serum 
was added to the melted agar just prior to use. Penicillin was added to the melted agar with 
the final concentration being 1000 units/ml. 
Preparation of Cell Wa//s.--Streptoeoccal cell walls were prepared as previously described 
(4).  For most purposes  the walls underwent additional purification by treatment with pro- 
teolytie enzymes and  RNAse and  DNAse. Throughout  this procedure,  care was  taken  to 
avoid contamination by Gram-negative organisms. All glassware,  including the Mickle cups 
and the Ballotini glass beads were sterilized by dry heat at 180°C for 2 hours. Sterile pyrogen- 
free water, prepared for intravenous use in patients, was used for washing the cell walls and 
for the preparation of the buffers for the enzyme treatment. The final cell wall preparations 
were stored in the lyophilized state. 
Preparation of Cell Wall Mucopeptide and Carbohydrate.--The group-specific  carbohydrate 
and the mucopeptide residue were obtained from cell walls by the formamide extraction pro- 
cedure  (4).  The separation of the carbohydrate  from the mucopeptide residue was demon- 
strated by the fact that the residue contained less than 1 per cent rhamnose. 
Preparative Injections.--The cell walls,  carbohydrate and mucopeptide residue as well as 
other control substances,  were suspended  in sterile saline just prior to injection into mice. 
The volume of all preparative injections was 0.25 ml. 
In some instances the mucopeptide employed in the preparative injection was solubilized 
by disintegration for 15 minutes in an MSE ultrasonic disintegrator, 20 kc. For this process 
the concentration of mucopeptide was 1 mg/ml. Mter ultrasonic treatment residual particu- 
late material was removed by eentrifugation, and the supernatant  containing the solubilized 
mucopeptide was used for injection. 
Detection of Pyrogenic Effect of Musopeptide.--Albino  rabbits,  1.5  to  1.7  kg,  maintained 
on an  antibiotic-free diet,  were employed in the fever studies.  Temperature  was recorded 
from the rectum. All rabbits had a normal temperature for at least 24 hours prior to experi- 
mental injection. 
Serological Identification of Streptococci and L Forms.--Streptococci  were identified by the 
capillary preeipitin technique of Swift,  Wilson, and Lancefield (5).  L  forms were identified 
by the immunofluorescent technique of Karakawa et al. (6). 
EXPERIMENTAL 
Enhanced Resistance.--Enhanced  resistance  to  a  subsequent  intraperitoneal 
challenge  with  virulent  Group  A  streptococci  commences  4  hours  after  an 
intraperitoneal  injection  of  Group  A  cell  walls  and  persists  for  at  least  72 ROTTA,  PRENDERGAST~ KARAKAWA, HARMON,  AND  KRAUSE  879 
hours  (2).  It is  apparent  from the  following  experiment  that  the  serologic 
type of the preparative dose of cell walls need not be identical to that of the 
challenge  dose of streptococci.  Two groups of mice were given an intraperi- 
toneal preparative dose of 250 #g of trypsinized Type 6  cell walls  and  two 
groups  of control  mice were injected  with  saline.  24  hours  later  one  group 
receiving  the  preparative  dose  and  one  group  receiving  the  saline  injection 
were  challenged  intraperitoneally  with  Type  6  streptococci.  The  other  two 
similar groups of mice were challenged with Type 14 streptococci.  Recorded 
in Table I  are the number of mice in each group and the number of mice stir- 
TABLE I 
Increased Survival of Mi~e Whick Received an Intraperitoneal Preparative Injection of Type 6 
Cell Walls Prior to Intraperitoneal Challenge ~qtk Homologous and Heterologous 
Streptococci 
Preparative injection* intraperitoneal 
type 6 cell walls 
~aline 









No. of mice 




2  I  '  7 
8  8  7 
7  2  1 
12  11  10 
5  2  1 
* Preparative injection: 24 hours prior to challenge each mouse received intraperitoneaUy 
250/zg of enzymatically treated Type 6 cell walls suspended in 0.25 ml saline. 
:~ Challenge was administered 24 hours after the preparative  injection: Type 6 strepto- 
cocci, 0.2 ml of a 10  -4 dilution of a standard culture of $43/100; Type 14 streptococci, 0.2 
ml of a 10-  3 dilution of a standard culture of T14 (PY). 
viving 2,  4,  and  7 days after challenge.  It is apparent that resistance to the 
heterologous Type  14  challenge is  equal  to  that  of  the  homologous Type  6 
challenge. 
Enhanced  Resistance  Stimulated  by  Cell  Wall  Mucopeptide.--Group  A  cell 
walls contain three major types of constituents; protein, including  the M, T, 
and  R  antigens,  the  group-specific carbohydrate,  and  the  mucopepfide.  Be- 
cause a preparative injection of the Group A cell walls, devoid of the proteins 
and adherent nucleic acids, was as effective in stimulating enhanced resistance 
as was a  preparative injection of cell walls which had not been treated with 
enzymes, experiments were designed to associate the enhancement of resistance 
with either  the soluble carbohydrate or the mucopeptide fraction of the cell 
walls. The soluble carbohydrate and the insoluble residue were prepared from 
cell walls by extraction with formamide at 180°C. 880  STREPTOCOCCAL INFECTIONS 
The  resistance  of  mice  to  streptococcM  challenge  following  pretreatment 
with  cell walls, carbohydrate, or mucopepfide was detected as follows. A  set 
consisting of three groups of ten 22  gm Swiss male mice were injected intra- 
peritoneally with each of the  three preparative materials 24 hours prior to a 
challenge  with  Group  A,  Type  6,  streptococci,  Strain  $43/100.  Another  set 
of three groups of control mice received a  preparative dose of saline prior to 
TABLE II 
Increased  Survival  of Mice which  Received an  Intraperitoneal  Preparative  Injection  of Cell 







Challenge dose of 
$43/100 streptoCocci 
0.2 ml intraperltoneal 
10  -~ dilution 
10-a  ,, 
10-4  ,, 
10-2  - 
lO-a  ,, 
10-4  ,, 
10-2  - 
10-z  " 
10-4  - 
10-2  ,, 
10-s  ,, 
10-4  ,, 















Days after challenge 
?  2  4 
1  1 
1  1 
9  7 
6  5 
10  10 
10  8 
1  0 
2  1 
8  6 
5  2 
8  8 




* Preparative injections were administered 24 hours prior to the challenge dose of strep- 
tococci: saline, 0.25 ml sterile saline; ceil walls, 250 #g of T6 ceil walls; carbohydrate, 250 
Izg of carbohydrate from T6 cell walls;  mucopeptide, 250/2g  of mucopeptide from T6 cell 
walls. 
challenge.  The  challenge  doses  of  streptococci  for  the  three  groups  of mice 
for each set are as follows: 0.2 ml of a  1 X  10  -2,  1 X  10-  8, and 1  X  10  -4 dilu- 
tions of the standard culture. The surviving mice 2,  4,  and  7 days after chal- 
lenge are recorded in Table II.  It is clear that  the  cell walls and  the muco- 
pepfide enhanced survival of the mice, whereas the carbohydrate wasineffective 
in this respect. 
A possible criticism of this experiment is that contamination with endotoxin 
of Gram-negative bacteria may have inadvertently occurred during the prepa- 
ration of the cell walls. If such were the case, the enhanced resistance exhibited ROTTA, P1LENDERGAST, KARAKAWA, HAIhMON, AND KRAUSE  881 
by  the  mice following injection  of cell  walls  might  be  dependent  upon  the 
contaminating endotoxin and not upon a  cell wall constituent.  It is unlikely, 
however, that the activity of the mucopeptide is dependent upon contaminat- 
ing  endotoxin,  because  this  cell wall fraction has undergone  treatment with 
formamide at  180°C,  conditions which should inactivate the protective effect 
of endotoxin. To clarify this point Difco endotoxin was heated with formamide 
in  the same manner employed to extract carbohydrate from cell walls.  It is 
clear from the data in Table III that endotoxin following such treatment did 
not enhance the resistance of mice to subsequent challenge. 
TABLE III 
Survival of Mice which Received an Intraperitoneal Preparative Injection of Active and Inac- 
tivated Endotoxin Prior to Intraperitoneal Challenge with Group A  Streptococci 
Preparative injection* intraperitoneal 
~Lne  ............................................. 
Cell walls  .......................................... 
Endotoxin ......................................... 
Endotoxin, inactivated  (hot formamide)  ............... 
No. of mice 
injected 
Survivors 
Days after challenge 
10  0  0  0 
10  I0 
10  10  8  8 
lO  '1  o 
Challenge dose: $43/100; 0.2 ml of 10  -4 dilution of standard culture. 
* Preparative  materials were injected intraperitoneally in a  0.25 ml volume 24  hours 
prior to challenge: cell walls, 250 #g; endotoxin, 5/~g; endotoxin, inactivated;  Dffco endo- 
toxin was treated with formamide at 180°C for 30 minutes. The precipitate which formed 
with the addition of 2 volumes of acid alcohol was discarded and 5 volumes of acetone added. 
The precipitate was collected from the alcoholic solution by centrifugation, taken up in a 
minimal volume of water, dialyzed, and lyophilized. 5 #g was injected. 
Because the protective effect of the mucopeptide may be primarily dependent 
upon the initiation of a  peritoneal inflammatory reaction, an experiment was 
performed to compare the enhanced resistance achieved with mucopeptide to 
that  obtained  with  other  irritant  substances.  The  results  are  presented  in 
Table IV. It is to be noted that enhanced resistance is exhibited by the mice 
which received streptococcal cell walls and endotoxin but not by other materials 
including  thorotrast,  carbon,  glycogen, and paraffin oil.  Furthermore,  muco- 
peptide solubilized by ultrasonic treatment was capable of inducing enhanced 
resistance. Thus, this property of the insoluble mucopeptide is not dependent 
solely on its particulate nature. 
Pyrogenic Effect of Mucopeptide.--Rabbits  which are injected intravenously 
with heat-killed streptococci develop elevations of body temperature (1).  Al- 
though one or more streptococcal substances may be responsible for this pyro- 882  STREPTOCOCCAL INFECTIONS 
genie  response,  intravenous  injection  of  solubilized mucopeptide  elicited a 
characteristic endotoxin febrile reaction in rabbits. The temperature curves ob- 
tained in  a  typical experiment  are  depicted, in  Fig.  1.  Rabbits  which  were 
injected with 2 mg of particulate mucopeptide did not exhibit a febrile response, 
whereas  other  rabbits  which  were  injected with  solubilized mucopepfide de- 
veloped fever. In this experiment 2 mg of insoluble mucopeptide were treated 
for 20 minutes in the MSE ultrasonic disintegrator, 20 kc. The product, con- 
TABLE IV 
Survival of Mice Which Received an Intraperitoneal Preparative Injection  of Particulate and 
Non-particulate Materials Prior to Intraperitoneal Challenge With Group A 
Streptococci 
Preparative  injection  intraperitoneal* 
Saline.. 
T6 cell walls, 250/zg. 
Endotoxin, 5/~g. 
Thorotrast, 250 #g 
Carbon, 250 #g 
Glycogen, 250 #g. 
Paraffin oil, 0.1 ml.. 
Mucopeptide, particulate.. 
Mucopeptide, solubilized. 












Days after challenge 
2  4  7 
0  0  0 
8  8  7 
10  9  7 
0  0  0 
1  1  1 
0  0  0 
5  2  2 
10  8  8 
10  8  7 
Challenge dose: $43/100;  0.2 ml of 10  -4 dilution of standard culture. 
* Preparative materials were injected intrapcritoneally in a volume of 0.25 ml, with the 
except of paraffin  oil as noted above, 24 hours prior to challenge: particulate mucopeptide, 
250/~g; solubilized mucopeptide,  500 #g of mucopeptide were exposed to ultrasonic treatment 
for 15 minutes and centrifuged  at  10,000 RPM for 30 minutes. Under these conditions the 
supernatant contained 50 per cent of the total hexosamine in the initial insoluble material. 
The supernatant was employed as the preparative dose and in terms of hexosamine content 
was equal to the insoluble mucopeptide dose. 
sisfing of both  solubilized and  particulate material,  was injected.  It is con- 
ceivable that better means of solubilization will yield a mucopeptide preparation 
with greater pyrogenic properties. In other preliminary experiments designed 
to achieve a  more active preparation, a febrile response was detected in rabbits 
after injection of 50 #g of solubilized mucopeptide. 
Enhanced Resistance Following Intravenous Injection  of Cell Walls.--To  cir- 
cumnrent  the  possibility that  the  enhanced  resistance  was  dependent  solely 
upon  a  peritoneal inflammatory reaction secondary to  the preparative injec- 
tion,  the  preparative  dose  of  cell walls  was  injected  intravenously  and  the ROTTA, PRENDERGAST, KARAKAWA, HARMON, AND KRAUSE  883 
challenge dose of streptococci intraperitoneally. The cell walls were solubilized 
by ultrasonic treatment to minimize the microembollc effect due to intravenous 
injection of particulate material. A preliminary test indicated that solubiliza- 
tion of the  cell walls  did  not  destroy their capacity to  stimulate  enhanced 
resistance. 
The results of an experiment with different time intervals between the intra- 
venous  preparative injection  and  subsequent  intraperitoneal  challenge  are 
recorded in Table V. Ten mice were injected intravenously with the cell wall 
I.V.  INJECTION 
2  -  Particulate  Mucopeptide 
o 
W 







I  i  I  I  I  I 
2  4  6 
HOURS 
I.V.  INJECTION 
" Solubilized  Mucopeptide 
0  2  4  6 
HOURS 
FIO. 1. Recorded on the right are  the febrile responses for 3 rabbits after intravenous 
injection of 2 mg of solubilized streptococcal  mucopeptide.  Absence  of fever after intravenous 
injection of 2 mg of insoluble mucopeptide  is recorded on the left. 
preparation and 10 control mice were injected intravenously with saline, and 
4  hours later both groups received the  challenge dose of  streptococci intra- 
peritoneally.  Similar  groups  of prepared  and  control mice  were  challenged 
intraperitoneally at  12 and 24 hours.  The number of surviving mice during 
the 1st week are recorded in the table. It is to be noted that when the interval 
between the preparative dose and the challenge dose was 12 hours, the majority 
of the mice survived challenge. This protective effect was of short duration, 
however, because no  appreciable protective effect was  detectable when  the 
interval was lengthened to 24 hours. 
Long Term Survival of Mice Receiving a Preparative Injection  of Cell Walls.- 
In all of these experiments resistance has been enhanced by an intraperitoneal 
preparative injection so that the majority of the mice inoculated with a lethal 
dose of streptococci survived at least  7 days. Although mice without a  pre- 884  STREPTOCOCCAL  INFECTIONS 
parative injection usually die within  the  1st week after a  streptococcal injec- 
tion, it was possible to demonstrate enhanced  survival beyond  the  1st week 
for the mice which received a preparative injection of cell walls. The results of 
a  typical experiment are depicted in Table VI. Eighty control mice received 
a preparative intraperitoneal injection of saline and 60 mice received 250 #g of 
cell walls.  24 hours later both groups of mice were injected with 0.5  ml of a 
10  -6 dilution  of a  standard  culture  of $43/100.  The surviving mice were re- 
corded at  1,  2, and 6 weeks. From an inspection  of  the  data in  Table  VI it 
TABLE  V 
Increased  Survival  of Mice Which Receive an Intravenous  Injection of Solubilized  Group A  Cell 






























Days after  challenge 
2  4  7 
10 
5 
* Preparative injection: Volume 0.25 ml; 250 #g of T6 cell walls solubilized by ultrasonic 
disintegration. 
:~ Challenge dose: 0.2 ml of a 10  -4 dilution of a standard culture of $43/100. 
is  obvious  that  the  preparative injection  of  cell  walls  enhances  survival  at 
least to the 6th week after challenge.  Bacteriologic study at the time of au- 
topsy of the  surviving mice revealed streptococci in  some mice as late as  6 
weeks after challenge.  Recovery of streptococci from blood and organs is en- 
hanced,  however, if the mice are given cortisone for 4  days prior to killing. 
Such persistence is associated in some instances with visible abscesses, although 
autopsy search  of many mice does not reveal an obvious infectious process. 
While  the  anatomical focus for the persistence of the  streptococcus may be 
obscure,  persistence is minimized if the mice are injected  with cell walls  24 
hours prior to challenge. 
The experiment recorded in Table VII demonstrates the influence of a pre- 
parative injection  of cell  walls  on  the  subsequent  recovery of  streptococci. 
One half of the prepared and the control mice which  survived 2 weeks after ROTTA,  PRENDERGAST,  KARAKAWA,  HARMON,  AND  KI~USE  885 
challenge were given cortisone, and the other half saline injections. A similar 
scheme was employed for the mice which survived through the 7th week. All 
mice were autopsied and cultures taken from hearts' blood, liver, spleen, kidney, 
and peritoneum. For the 7-week mice, at the time of death or killing, Group A 
streptococci were cultured from the majority of the mice which had not re- 
ceived a  preparative injection of cell walls  prior  to  challenge.  In  contrast, 
Group A streptococci were detected infrequently in those mice which had had 
a preparative injection. 
Bacteriologic Studies on the Persistent Infection.---The foregoing studies indi- 
cate  that  Group A  streptococci will persist for many weeks in mice which 
TABLE VI 
Long  Term Survival of Mice Which Received an Intraperitoneal Preparative Injection  of Cell 
Walls Prior to Intraperitoneal Challenge with Group A Streptococci 
Preparative injection 
intraperitoneal* 
No. of mice 
injected 
Survivors 
Weeks after Challenge 
1  2  6 
Saline .................  80  55  (69%)  43  (54%)  35  (46%) 
Cell walls  ..............  60  54  (90%)  53  (89%)  50  (84%) 
Challenge dose: 0.5 ml of 10  -6 dilution of a standard culture of $43/100. 
* Preparative injection of 250 ~g of Type 6 cell walls was administered 24 hours prior to 
challenge. 
survive the initial challenge of streptococci. These bacteria of the same serologic 
type as  those in the initial injection were recovered from hearts'  blood and 
various  organs including  kidney,  liver,  and  spleen.  In  general,  the  bacteria 
were recovered from all  the  organs  of those mice which  received cortisone, 
but were much less likely to be disseminated when cortisone was withheld. 
Wilson (7) described the occurrence of Group A-variant streptococci (8,  9) 
during  serial  mouse  passage  of  Group  A  streptococci,  and  Lancefield  (10) 
identified these variants in mice suffering from a cervical adenitis due to Group 
A  streptococci Type 50.  A  similar antigenic alteration was noted in the per- 
sistent streptococci of the  experiments reported here.  For instance,  Type 6, 
Group A-variant streptococci were cultured 5 weeks after injection from 8 of 
10 mice which were positive for Type 6 streptococci. In the case of Type 14, 
4 of 8 positive mice harbored Group A-variant streptococci and 1 mouse har- 
bored Group A intermediate streptococci. 
Throughout  these  studies  numerous  attempts  were  made  at  the  time  of 
autopsy to isolate L  forms from peritoneal fluid, the organs, and the hearts' 
blood of mice which died or were killed within 48 hours after infection, and 886  STREPTOCOCCAL  INFECTIONS 
from similar material of mice which  survived for longer periods.  Although L 
forms were readily recovered, particularly from the peritoneal exudate, in no 
instance were the L forms recovered from material which did not reveal Group 
A  streptococci.  Thus,  it is conceivable  that  the L  forms were not  recovered 
from the autopsy material but were, in fact, produced in vitro from the strepto- 
cocci in the inoculum by the penicillin in the L  form media. 
To answer this  question  the peritoneum of infected mice was washed with 
2 per cent NaC1 broth and an aliquot passed through a  Millipore filter with a 
TABLE  VII 
Recovery of Streptococci from Mice Which Survive  2 and 7 Weeks after Challenge: Effect  of a 































No. of mice at 
death or killing 




Challenge dose: 0.2 ml of 10  -8 dilution of standard culture of $43/100. 
Cortisone treatment:  1.1 mg of cortisone intramuscularly daily for 4 days at the end of the 
2nd and  7th week after challenge. 
* Preparative injection of 250 #g of cell walls was administered 24 hours prior to challenge. 
porosity of 0.65 #.  The filtered and non-filtered peritoneal fluid was cultured 
on regular blood agar and L form agar. For 1 mouse the peritoneal fuid, prior 
to filtration, contained 1 X  105 colony-producing L forms, and after filtration, 
1 X  1@. This diminution in numbers after filtration has been noted with other 
experiments and probably represents not only retention  but also destruction 
of the filtered forms by the Millipore membrane. Representative colonies of 
the  filterable  L  forms  were identified  serologically  by  previously  described 
immunofluorescent techniques  (6).  In all cases the M  protein was identical to 
that of the initial streptococci injected into the mouse. The peritoneal washing, 
prior to filtration,  contained  108 colony-producing streptococci as detected on 
blood agar plates, whereas the cultures of the filtered material did not exhibit 
streptococcal colonies after 18 hours of incubation.  During additional incuba- ROTTA, PRENDERGAST, KARAKAWA, HAP,~ON, AND  KRAUSE  887 
tion over a 48 hours period, a few small atypical colonies with a faint hemolytic 
zone appeared on the blood plates.  These streptococci, after subculture,  de- 
veloped into typical beta hemolytic colonies and were identified as Group A 
Type 6. It should be emphasized that repeated cultures of the MiBipore filtrates 
of regular streptococcal cultures were sterile on both blood agar and L  form 
agar. These data suggest that a  predominant number of the viable filterable 
forms grew as L  forms, but a few had the capacity to revert to streptococci. 
In addition, it is conceivable that a limited number of the filterable forms are 
intermediate structures which have the potential, depending upon the cultural 
conditions, to develop either as L  forms or as bacteria. The identification in 
the peritoneal washing of viable filterable forms which develop as L form col- 
onies supports the view that the streptococcal L forms were the result of altera- 
tions of streptococci within the mouse and do not represent in vitro conversion 
of the bacteria to L forms. 
DISCUSSION 
Dubos and  Schaedler have emphasized the reversible  changes in  the sus- 
ceptibility of mice to bacterial infections brought about by injections of pertus- 
sis vaccines, fractions of mycobacteria, and bacterial entotoxins (3,  11). Since 
these reports, such alterations of resistance to infections following administra- 
tion of various substances have been extensively reviewed  (12-15),  so  that 
this subject need not be discussed in detail here. In most instances in which 
the subject has been investigated,  these non-specific protective effects have 
been attributed to bacterial cell wall substances which have the chemical and 
biological properties  of  the  endotoxins  (14).  The precise mechanism of  the 
enhanced resistance initiated: in mice by endotoxin has not been clarified. It 
has been shown that endotoxin markedly altered the clearance capacity of the 
reticuloendothelium system (15), and that the bacteriocidal power of the serum 
for Escherichia coli was elevated after injection (16). Serum from mice injected 
with endotoxin exhibited increased opsonic power as measured by blood clear- 
ance of P~-labeled E. coli (15). Finally, Whitby et al.(14), and others, have sug- 
gested that preexisting antibody to the challenge organism is a requirement for 
the elucidation of the endotoxin-induced increased resistance. It is probable that 
none of these currently described mechanisms are solely responsible for this 
biological property of endotoxin. 
The experiments reported here indicate that mucopeptlde isolated from the 
streptococcal cell wall has at least two of the biological properties attributed 
to the endotoxins of Gram-negative bacteria. Administration of mucopeptide 
to mice is followed by increased resistance to subsequent streptococcal chal- 
lenge, and injection into rabbits is followed by a febrile response. Stetson has 
studied in detail the endotoxic properties of the lysates of Group A strepto- 
cocci  (1).  In  this work, attention was directed  to  the cytoplasmic material 888  STREPTOCOCCAL  INFECTIONS 
obtained after removal,  by centrlfugafion, of the cell walls from streptococci 
which had been disrupted in a mechanical shaker. The endotoxic properties of 
the cytoplasm may have been dependent upon traces of cell wall mucopeptide 
solubilized  during  the mechanical disruption,  or,  alternatively, streptococci 
may contain a substance in addition to mucopeptide which possesses entotoxic 
properties.  These alternatives will require  further clarification.  Nevertheless, 
the evidence suggests that streptococcal  mucopeptide has certain of the bio- 
logical properties of endotoxin isolated from Gram-negative bacteria. From a 
chemical point of view, however,  there is no similarity between  the chemical 
content of streptococcal mucopeptide and that of endotoxin. On a weight basis 
endotoxin is greater than 10 times as effective as mucopeptide in stimulating 
enhanced resistance,  and is greater than 100  times as effective in eliciting  a 
febrile response in rabbits. 
A possible interpretation of these  data is that the mucopeptide was  con- 
taminated with endotoxin at some point in preparation.  This alternative is 
thought unlikely  in view of the preparative procedures  employed to isolate the 
mucopeptide.  It is yet to be learned if the mucopeptide of other bacteria also 
possesses endotoxic properties. 
The data reported here indicate that a preparative injection of endotoxin 
enhances the resistance of mice to subsequent challenge with Group A strepto- 
cocci. Michael and Massell failed to demonstrate a protective effect, but this 
failure was probably dependent upon the large  dose of virulent streptococci 
which was employed as the challenge in their experiments  (17). 
Other studies have drawn attention to the persistence in rabbits of Group A 
streptococci  after injection (18), and the recovery of streptococci in mice after 
6 to 10 weeks is consistent with these earlier  studies.  It was of interest that 
injection of mucopeptide prior to challenge with streptococci sufficiently stimu- 
lated resistance  so that persistence  of the streptococci was eliminated. 
No attempt will be made here to discuss in detail the recovery of strepto- 
coccal L forms from mice infected with Group A streptococci.  In agreement 
with the findings of Mortimer (19), the evidence suggests  that these  special 
forms of streptococci  were developed in the host. Certainly the isolation of L 
forms from the animal material requires  extensive  confirmation before  any 
biological  significance can be  attributed to  these  findings.  There are an in- 
creasing number of reports,  however, which suggest that L forms under certain 
circumstances  can be isolated from experimental  infections (20). 
SITMMARY 
The streptococcal  cell  wall mucopeptide  when injected into mice either 
intraperitoneally  or intravenously enhances the resitance  to subsequent chal- 
lenge with virulent Group A  streptococci.  Rabbits which are injected  intra- 
venously with solubilized mucopeptide develop a fever response  which has a 
resemblance to that achieved with endotoxin. ROTTA, PRENDERGAST, KAKAKAWA, HARMON~ AND KRAUSE  889 
Mice which survive 6  to 7 weeks after  challenge  with  virulent  Group  A 
streptococci yield at autopsy search Group A streptococci serologically identi- 
cal to the challenge organisms. A  preparative dose of cell walls injected into 
mice prior to challenge diminished this late recovery of streptococci. 
Group  A-variant  streptococci  were  recovered from  mice  which  survived 
challenge  and  carried  the  organisms  for  several  weeks.  Filterable  bacterial 
forms, which grew on L  form media, were recovered from infected mice. The 
serologic type of the L forms was identical to that of the challenge organisms. 
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